124 related articles for article (PubMed ID: 15566131)
1. The efficacy of a single daily dose of enoxaparin for deep vein thrombosis prophylaxis following total knee arthroplasty.
Pulido PA; Copp SN; Walker RH; Reden LM; Hardwick ME; Colwell CW
Orthopedics; 2004 Nov; 27(11):1185-7. PubMed ID: 15566131
[TBL] [Abstract][Full Text] [Related]
2. Surveillance venous duplex is not clinically useful after total joint arthroplasty when effective deep venous thrombosis prophylaxis is used.
Schwarcz TH; Matthews MR; Hartford JM; Quick RC; Kwolek CJ; Minion DJ; Endean ED; Mentzer RM
Ann Vasc Surg; 2004 Mar; 18(2):193-8. PubMed ID: 15253255
[TBL] [Abstract][Full Text] [Related]
3. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin versus No Anticoagulation Prophylaxis after Total Knee Arthroplasty in Thai Patients: A Randomized Controlled Trial.
Intiyanaravut T; Thongpulsawasdi N; Sinthuvanich N; Teavirat S; Kunopart M
J Med Assoc Thai; 2017 Jan; 100(1):42-9. PubMed ID: 29911379
[TBL] [Abstract][Full Text] [Related]
6. Incidence of deep vein thrombosis before and after total knee arthroplasty without pharmacologic prophylaxis: a 128-row multidetector CT indirect venography study.
Chang MJ; Song MK; Kyung MG; Shin JH; Chang CB; Kang SB
BMC Musculoskelet Disord; 2018 Jul; 19(1):274. PubMed ID: 30064411
[TBL] [Abstract][Full Text] [Related]
7. Post-thrombotic syndrome after total hip or knee arthroplasty: incidence in patients with asymptomatic deep venous thrombosis.
Schindler OS; Dalziel R
J Orthop Surg (Hong Kong); 2005 Aug; 13(2):113-9. PubMed ID: 16131671
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study.
Heit JA; Colwell CW; Francis CW; Ginsberg JS; Berkowitz SD; Whipple J; Peters G;
Arch Intern Med; 2001 Oct; 161(18):2215-21. PubMed ID: 11575978
[TBL] [Abstract][Full Text] [Related]
9. Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
Özler T; Uluçay Ç; Önal A; Altıntaş F
Acta Orthop Traumatol Turc; 2015; 49(3):255-9. PubMed ID: 26200403
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty.
Stern SH; Wixson RL; O'Connor D
J Arthroplasty; 2000 Feb; 15(2):153-8. PubMed ID: 10708078
[TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of DVT with enoxaparin in patients undergoing total knee replacement.
Niazi AU; Umer M; Umar M
J Pak Med Assoc; 2006 Feb; 56(2):72-5. PubMed ID: 16555639
[TBL] [Abstract][Full Text] [Related]
12. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Bawa H; Weick JW; Dirschl DR; Luu HH
J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
[TBL] [Abstract][Full Text] [Related]
13. Deep Venous Thrombosis Prophylaxis After Unicompartmental Knee Arthroplasty: A Prospective Study on the Safety of Aspirin.
Schmidt-Braekling T; Pearle AD; Mayman DJ; Westrich GH; Waldstein W; Boettner F
J Arthroplasty; 2017 Mar; 32(3):965-967. PubMed ID: 27789095
[TBL] [Abstract][Full Text] [Related]
14. Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis.
Huang HF; Li SS; Yang XT; Xie Q; Tian XB
Medicine (Baltimore); 2018 Nov; 97(48):e13465. PubMed ID: 30508972
[TBL] [Abstract][Full Text] [Related]
15. Pneumatic compression device does not show effective thromboprophylaxis following total knee arthroplasty in a low incidence population.
Kim KI; Kim DK; Song SJ; Hong SJ; Bae DK
Orthop Traumatol Surg Res; 2019 Feb; 105(1):71-75. PubMed ID: 30555017
[TBL] [Abstract][Full Text] [Related]
16. Deep vein thrombosis after total knee arthroplasty in asian patients without prophylactic anticoagulation.
Chung LH; Chen WM; Chen CF; Chen TH; Liu CL
Orthopedics; 2011 Jan; 34(1):15. PubMed ID: 21210628
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of asymptomatic deep vein thrombosis after total knee arthroplasty in Japanese patients.
Tateiwa T; Ishida T; Masaoka T; Shishido T; Takahashi Y; Onozuka A; Nishida J; Yamamoto K
J Orthop Surg (Hong Kong); 2019; 27(2):2309499019848095. PubMed ID: 31084257
[TBL] [Abstract][Full Text] [Related]
18. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
Weitz JI; Bauersachs R; Becker B; Berkowitz SD; Freitas MCS; Lassen MR; Metzig C; Raskob GE
JAMA; 2020 Jan; 323(2):130-139. PubMed ID: 31935028
[TBL] [Abstract][Full Text] [Related]
19. Efficacy in Deep Vein Thrombosis Prevention With Extended Mechanical Compression Device Therapy and Prophylactic Aspirin Following Total Knee Arthroplasty: A Randomized Control Trial.
Snyder MA; Sympson AN; Scheuerman CM; Gregg JL; Hussain LR
J Arthroplasty; 2017 May; 32(5):1478-1482. PubMed ID: 28159420
[TBL] [Abstract][Full Text] [Related]
20. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
Yamaguchi T; Hasegawa M; Niimi R; Sudo A
Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
